Characteristics of Young Children Hospitalized With Acute Respiratory Failure From Infection With Respiratory Syncytial Virus, SARS-CoV-2, or Both, November 2023-March 2024.
(2026 Mar)
Open Forum Infect Dis 13(3): ofag088
Simeone RM, Newhams MM, Zambrano LD, Calixte JM, Lindsey K, Orzel-Lockwood A, Payne AB, Halasa NB, Kamidani S, Maddux AB, Chiotos K, Crandall H, Schuster JE, Zerr DM, Martin LM, Cameron MA, Irby K, Gertz SJ, Shein SL, Nofziger RA, Bhumbra SS, Hume JR, Kong M, Maamari M, Coates BM, Guzman-Cottrill JA, Staat MA, Connors TJ, Zinter MS, Chauhan JC, Bradford TT, Wellnitz K, Campbell AP, Randolph AG, Overcoming COVID-19 Investigators

Interim Estimates of 2025-26 Seasonal Influenza Vaccine Effectiveness - United States, September 2025-February 2026.
(2026 Mar 12)
MMWR Morb Mortal Wkly Rep 75(9): 116-123
Maloney P, Reeves EL, Wielgosz K, Price AM, Natarajan K, DeSilva MB, Dascomb K, Klein NP, Tartof SY, Irving SA, Grannis SJ, Ong TC, Weber ZA, Schuster JE, Zerr DM, Michaels MG, Boom JA, Halasa NB, Staat MA, Weinberg GA, House SL, Saade EA, Geffel KM, Gaglani M, Wernli KJ, Murugan V, Martin ET, Bontrager NAB, Kirby MK, Payne AB, Dawood FS, Tannis A, Moline HL, Zhao SK, Adams K, DeCuir J, Olson SM, Chung JR, Lewis N, Flannery B, Reed C, Garg S, Ellington S, CDC Influenza Vaccine Effectiveness Collaborators, CDC Influenza Vaccine Effectiveness Collaborators

Nirsevimab Effectiveness Against Intensive Care Unit Admission for Respiratory Syncytial Virus in Infants - 24 States, December 2024-April 2025.
(2025 Nov 20)
MMWR Morb Mortal Wkly Rep 74(37): 580-588
Zambrano LD, Simeone RM, Newhams MM, Payne AB, Halasa NB, Orzel-Lockwood AO, Calixte JM, Kamidani S, Crandall H, Cameron MA, Schuster JE, Maddux AB, Chiotos K, Irby K, Shein SL, Staat MA, Martin LM, Bhumbra SS, Nofziger RA, Chauhan JC, Zerr DM, Gertz SJ, Guzman-Cottrill JA, Kong M, Hume JR, Coates BM, Michelson KN, Levy ER, Bradford TT, Schwartz SP, Walker TC, Stockwell MS, Biggs A, Hogan AH, Lindsey K, Campbell AP, Randolph AG, Overcoming RSV Investigators

Endogenous human herpesviruses 6A/B.
(2025 Sep 23)
J Virol 99(9): e0105425
Flamand L, Arbuckle J, Bonnafous P, Descamps V, Hill JA, Jarrett R, Jerome K, Kaufer BB, Koide R, Komaroff AL, Medveczky P, Miura H, Mori Y, Parrish N, Pellett PE, Wood M, Yoshikawa T, Zerr DM

American Society for Transplantation and Cellular Therapy Series #9: Management of Human Herpesvirus 6B After Hematopoietic Cell Transplantation and Chimeric Antigen Receptor-T-Cell Therapy.
(2025 Aug)
Transplant Cell Ther 31(8): 480-493
Kampouri E, Handley G, Phan TL, Lee YJ, Shaw R, Carpenter PA, Dadwal SS, Chemaly RF, Papanicolaou GA, Ogata M, Boeckh M, Zerr DM, Hill JA